Clinical trials: Coagulation Management
Rheumatoid Purpura
Rheumatoid Purpura in Children: a Multicenter Observational Study of Pediatric Emergency Department Management and Follow-up by Primary Care Physicians
The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up by primary care physicians after hospital discharge.
- Trial name
- PREEMS (NCT05737056)
- Testing
- Management of rheumatoid purpura
- Where
- 2 sites in France
- Volunteers
- 66 people
- Sponsor
- Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Immune Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic
Rituximab Combining Bortezomib Versus Rituximab in Management of ITP
The project was undertaking by Qilu Hospital of Shandong University and other 2 well-known hospitals in China. In order to report the efficacy and safety of rituximab combining with bortezomib for the treatment of adults with…
- Trial name
- NCT03443570
- Testing
- Rituximab, Bortezomib
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Shandong University
Ebola Virus Disease, Marburg Virus Disease
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Primary Objective: To evaluate the safety and tolerability of cAd3-EBO-S and cAd3 Marburg vaccines when administered Intramuscular (IM) at a dose of 1 x 10^11 particle units (PU) to healthy adults.
- Trial name
- NCT04723602
- Testing
- cAd3-Marburg, cAd3-EBO-S
- Where
- United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Albert B. Sabin Vaccine Institute
Immune Thrombocytopenia
Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of caffeic acid tablets combining with high-dose dexamethasone for the treatment of adults with…
- Trial name
- NCT02556814
- Testing
- Caffeic acid tablets, Dexamethasone
- Where
- China
- Volunteers
- 214 people
- Sponsor
- Shandong University
Pain, Hypoglycemia
Outcomes Study of MTM in a Medicare ACO
This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department…
- Trial name
- NCT02875925
- Testing
- MTM
- Where
- United States
- Volunteers
- 77 people, healthy volunteers welcome
- Sponsor
- HealthEast Care System
Von Willebrand Disease
Molecular and Clinical Profile of Von Willebrand Disease in Spain
The present Project is a third phase of the previous PCM-EVW-ES Project (Batlle et al. Thromb \& Haemost 2015) with the aim of its extension, further analysis with an innovation development in the field of von Willebrand disease…
- Trial name
- PCM-EVW-ES (NCT02869074)
- Testing
- VWF gene analysis
- Where
- Spain
- Volunteers
- 790 people, healthy volunteers welcome
- Sponsor
- Spanish Society of Thrombosis and Haemostasis
vonWillebrand Disease, Hemophilia
The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments.
- Conditions
- vonWillebrand Disease, Hemophilia, Platelet Coagulation Disorders
- Trial name
- NCT00697385
- Testing
- Cyclokapron
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Mary M. Gooley Hemophilia Center
Hemophilia A
Early Prophylaxis Immunologic Challenge (EPIC) Study
The purpose of the study was to assess if a once-weekly prophylactic regimen of 25 IU/kg ADVATE started at or before 1 year of age and before the onset of a severe bleeding phenotype (ie, joint bleeding), together with the…
- Trial name
- EPIC (NCT01376700)
- Testing
- Recombinant antihemophilic factor, plasma/albumin-free method (rAHF-PFM)
- Where
- 19 sites in United States, Austria and 10 more
- Volunteers
- 22 people
- Sponsor
- Baxalta now part of Shire
Patient Blood Management
Impact of Patient Blood Management (PBM) at the Schulthess Clinic
Aim of this study is to analyze the transfusion requirements of allogenic blood products at the Schulthess Clinic for patients that had major orthopedic or major spine surgery between 2019 and 2024 order to identify patients at…
- Trial name
- PBM (NCT06363214)
- Testing
- Patient blood management
- Volunteers
- 16,000 people
- Sponsor
- Schulthess Klinik
Immune Thrombocytopenia, Purpura, Thrombocytopenic
Atorvastatin in Management of Newly Diagnosed ITP
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of atorvastatin for the treatment of adults with immune thrombocytopenia (ITP).
- Trial name
- NCT03692754
- Testing
- Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shandong University
Immune Thrombocytopenia
A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）
The project was undertaking by Qilu Hospital of Shandong University and other 5 well-known hospitals in China. In order to report the efficacy and safety of recombinant human thrombopoietin combining with cyclosporin A for the…
- Trial name
- NCT02203422
- Testing
- Cyclosporin A, rhTPO
- Where
- China
- Sponsor
- Shandong University
Coagulopathy
Assessment of Artificial Intelligence Algorithms for ROTEM
The goal of this observational validation study is to evaluate whether artificial intelligence (AI) models can accurately interpret ROTEM (Rotational Thromboelastometry) data and provide appropriate treatment recommendations in…
- Trial name
- NCT07043556
- Testing
- Artificial Intelligence-Based ROTEM Interpretation
- Where
- 2 sites in Turkey (Türkiye)
- Sponsor
- Ondokuz Mayıs University
Antithrombin III Deficiency
Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate
To assess the safety, pharmacokinetics and efficacy of a plasma-derived AT-III concentrate in the treatment of subjects with congenital AT-III deficiency.
- Trial name
- NCT00319228
- Testing
- Plasma-derived AT-III concentrate
- Volunteers
- 3 people
- Sponsor
- Instituto Grifols, S.A.
Purpura, Idiopathic Thrombocytopenic Purpura
rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP
The project was undertaking by Qilu Hospital of Shandong University and other 13 well-known hospitals in China. In order to report the efficacy and safety of Recombinant Human thrombopoietin combining with Rituximab for the…
- Trial name
- NCT01525836
- Testing
- rituximab; recombinant human thrombopoietin (rhTPO), Rituximab
- Where
- China
- Volunteers
- 123 people
- Sponsor
- Shandong University
Gastrointestinal Hormones, Glycemic Control
Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose
This project aims to compare the acute metabolic effects of the three sweeteners sucrose, glucose, and fructose on GI hormones (GLP-1, PYY, CCK, GIP, and ghrelin).
- Conditions
- Gastrointestinal Hormones, Glycemic Control, Blood Coagulation Function, Gastric Emptying
- Trial name
- NCT06799715
- Testing
- Sucrose, Glucose, Fructose
- Where
- Switzerland
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome
Rituximab in Patients With Relapsed or Refractory TTP-HUS
The general objective of this study is to assess the efficacy and safety of Rituximab in the management of patients with refractory or relapsed thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS).
- Trial name
- NCT00531089
- Testing
- Rituximab
- Where
- 11 sites in Canada
- Volunteers
- 60 people
- Sponsor
- Hamilton Health Sciences Corporation
Thrombotic Thrombocytopenic Purpura (TTP)
A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program
Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare blood disorder that some people are born with. It is caused by inherited changes in the ADAMTS13 gene that reduce the body's ability to produce the ADAMTS13 enzyme.
- Trial name
- NCT07429942
- Testing
- No Intervention
- Where
- 8 sites in Germany, Poland
- Volunteers
- 94 people
- Sponsor
- Takeda
Disseminated Intravascular Coagulation
International Prospective Registry of Disseminated Intravascular Coagulation
Objectives: to evaluate the current diagnostic and therapeutic approaches for sepis-associated disseminated intravascular coagulation (DIC) in a large prospective registry.
- Trial name
- NCT03577015
- Where
- Netherlands
- Volunteers
- 1,000 people
- Sponsor
- Marcella Muller
Severe Hemophilia
Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
Therapy of patients with severe hemophilia (including hemophilia with inhibitors) and other severe bleeding disorders could be monitored and guided based upon special clotting assays , eg thrombin generation and…
- Trial name
- NCT02324517
- Where
- Israel
- Volunteers
- 300 people
- Sponsor
- Sheba Medical Center
Immune Thrombocytopenia
An Investigation of rhTPO With Different Frequencies in the Management of ITP
The project was undertaking by Qilu Hospital of Shandong University and other well-known hospitals in China. In order to study the efficacy and safety of different dose and frequency Recombinant Human thrombopoietin in treating…
- Trial name
- NCT02139501
- Testing
- Recombinant Human Thrombopoietin (rhTPO)
- Where
- China
- Volunteers
- 48 people
- Sponsor
- Shandong University